Pharming Q1 EPS $(0.22) Misses $(0.01) Estimate, Sales $79.10M Beat $67.73M Estimate

Benzinga · 05/08 07:39
Pharming (NASDAQ:PHAR) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.01) by 2100 percent. This is a 15.79 percent decrease over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $79.10 million which beat the analyst consensus estimate of $67.73 million by 16.78 percent. This is a 42.30 percent increase over sales of $55.59 million the same period last year.